Neoplasms by Site Recruiting Phase 3 Trials for Docetaxel (DB01248)

IndicationStatusPhase
DBCOND0030096 (Neoplasms by Site)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01917279Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBCTreatment